Leishmania infantum-chagasi activates SHP-1 and reduces NFAT5/TonEBP activity in the mouse kidney inner medulla

American Journal of Physiology - Renal Physiology

Volumn 307, Issue 5, 2014, Pages

  Zhou, Xiaoming ^a   Wang, Hong ^a   Koles, Nancy L ^a   Zhang, Aihong ^a   Aronson, Naomi E ^a  

^a Uniformed Services University of the Health Sciences   (United States)

Author keywords

Aquaporin 2; ERK1 2; Leishmaniasis; Urinary concentration; Virulence factors

Indexed keywords

PEPTIDES AND PROTEINS; PROTEIN NFAT5; PROTEIN TONEBP; PROTEIN TYROSINE PHOSPHATASE SHP 1; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID CARRIER; AQUAPORIN 2; COTRANSPORTER; NFAT5 PROTEIN, MOUSE; PTPN6 PROTEIN, MOUSE; SLC5A3 PROTEIN, MOUSE; SLC6A12 PROTEIN, MOUSE; STAT3 PROTEIN; STAT3 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; KIDNEY MEDULLA; LEISHMANIA CHAGASI; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN EXPRESSION; VISCERAL LEISHMANIASIS; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DISEASE MODEL; FEMALE; GENE EXPRESSION REGULATION; KIDNEY CONCENTRATING CAPACITY; KIDNEY CORTEX; LEISHMANIA INFANTUM; METABOLISM; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; AQUAPORIN 2; CELL LINE; DISEASE MODELS, ANIMAL; FEMALE; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GENE EXPRESSION REGULATION; KIDNEY CONCENTRATING ABILITY; KIDNEY CORTEX; KIDNEY MEDULLA; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MICE; MICE, INBRED BALB C; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; STAT3 TRANSCRIPTION FACTOR; SYMPORTERS; TRANSCRIPTION FACTORS;

EID: 84906895923     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00006.2014     Document Type: Article

References (65)

1. Alto NM, Orth K. Subversion of cell signaling by pathogens. Cold Spring Harb Perspect Biol 4: a006114, 2012.
2. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M; WHO Leishmaniasis Control Team. Leishmaniasis world-wide and global estimates of its incidence. PLoS One 7: e35671, 2012.
3. Alves GB, Silva LS, Batista JF, Campos AP, Prianti M, Costa FA. The sero-conversion and evaluation of renal alterations in dogs infected by Leishmania (Infantum) chagasi. Rev Inst Med Trop Sao Paulo 55: 105-112, 2013.
4. Basu BW, Kar S, Mukherjee M, Chande AG, Mukhopadhyaya R, Das PK. Uncoupling protein 2 negatively regulates mitochondrial reactive oxygen species generation and induces phosphatase-mediated anti-inflammatory response in experimental visceral leishmaniasis. J Immunol 187: 1322-1332, 2011.
5. Berens RL, Brun R, Krassner SM. A simple monophasic medium for axenic culture of hemoflagellates. J Parasitol 62: 360-365, 1976.
6. Berga-Bolanos R, Alberdi M, Buxade M, Aramburu J, Lopez-Rodriguez C. NFAT5 induction by the pre-T-cell receptor serves as a selective survival signal in T-lymphocyte development. Proc Natl Acad Sci USA 110: 16991-16096, 2013.
7. Berga-Bolanos R, Drews-Elger K, Aramburu J, Lopez-Rodriguez C. NFAT5 regulates T lymphocyte homeostasis and CD24-dependent T cell expansion under pathologic hypernatremia. J Immunol 185: 6624-6635, 2010.
8. Buffet PA, Sulahian A, Garin YJ, Nassar N, Derouin F. Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother 39: 2167-2168, 1995.
9. Burg MB, Ferraris JD, Dmitrieva NI. Cellular response to hyperosmotic stresses. Physiol Rev 87: 1441-1474, 2007.
10. Buxade M, Lunazzi G, Minguillon J, Iborra S, Berga-Bolanos R, Del VM, Aramburu J, Lopez-Rodriguez C. Gene expression induced by Toll-like receptors in macrophages requires the transcription factor NFAT5. J Exp Med 209: 379-393, 2012.
11. Chong ZZ, Maiese K. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol Histopathol 22: 1251-1267, 2007.
12. Costa FA, Goto H, Saldanha LC, Silva SM, Sinhorini IL, Silva TC, Guerra JL. Histopathologic patterns of nephropathy in naturally acquired canine visceral leishmaniasis. Vet Pathol 40: 677-684, 2003.
13. Daher EF, Rocha NA, Oliveira MJ, Franco LF, Oliveira JL, Silva Junior GB, Abreu KL, Henn GA, Martins AM, Liborio AB. Renal function improvement with pentavalent antimonial agents in patients with visceral leishmaniasis. Am J Nephrol 33: 332-336, 2011.
14. Dettwiler S, McKee T, Hadaya K, Chappuis F, van DC, Moll S. Visceral leishmaniasis in a kidney transplant recipient: parasitic interstitial nephritis, a cause of renal dysfunction. Am J Transplant 10: 1486-1489, 2010.
15. Dubois MJ, Bergeron S, Kim HJ, Dombrowski L, Perreault M, Fournes B, Faure R, Olivier M, Beauchemin N, Shulman GI, Siminovitch KA, Kim JK, Marette A. The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis. Nat Med 12: 549-556, 2006.
16. Faria MS, Reis FC, Lima AP. Toll-like receptors in Leishmania infections: guardians or promoters? J Parasitol Res 2012: 930257, 2012.
17. Ferraris JD, Williams CK, Persaud P, Zhang Z, Chen Y, Burg MB. Activity of the TonEBP/OREBP transactivation domain varies directly with extracellular NaCl concentration. Proc Natl Acad Sci USA 99: 739-744, 2002.
18. Forget G, Gregory DJ, Olivier M. Proteasome-mediated degradation of STAT1alpha following infection of macrophages with Leishmania donovani. J Biol Chem 280: 30542-30549, 2005.
19. Forget G, Gregory DJ, Whitcombe LA, Olivier M. Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production. Infect Immun 74: 6272-6279, 2006.
20. Go WY, Liu X, Roti MA, Liu F, Ho SN. NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. Proc Natl Acad Sci USA 101: 10673-10678, 2004.
21. Gomez MA, Contreras I, Halle M, Tremblay ML, McMaster RW, Olivier M. Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases. Sci Signal 2: ra58, 2009.
22. Granot-Attas S, Elson A. Protein tyrosine phosphatases in osteoclast differentiation, adhesion, and bone resorption. Eur J Cell Biol 87: 479-490, 2008.
23. Halterman JA, Kwon HM, Leitinger N, Wamhoff BR. NFAT5 expression in bone marrow-derived cells enhances atherosclerosis and drives macrophage migration. Front Physiol 3: 313, 2012.
24. Hassani K, Antoniak E, Jardim A, Olivier M. Temperature-induced protein secretion by Leishmania mexicana modulates macrophage signalling and function. PLoS One 6: e18724, 2011.
25. Kawakami T, Xiao W, Yasudo H, Kawakami Y. Regulation of proliferation, survival, differentiation, and activation by the signaling platform for SHP-1 phosphatase. Adv Biol Regul 52: 7-15, 2012.
26. Kumar R, Nylen S. Immunobiology of visceral leishmaniasis. Front Immunol 3: 251, 2012.
27. Kuper C, Fraek ML, Muller HH, Beck FX, Neuhofer W. Sepsisinduced urinary concentration defect is related to nitric oxide-dependent inactivation of TonEBP/NFAT5, which downregulates renal medullary solute transport proteins and aquaporin-2. Crit Care Med 40: 1887-1895, 2012.
28. Lambertz U, Silverman JM, Nandan D, McMaster WR, Clos J, Foster LJ, Reiner NE. Secreted virulence factors and immune evasion in visceral leishmaniasis. J Leukoc Biol 91: 887-899, 2012.
29. Lanaspa MA, Andres-Hernando A, Li N, Rivard CJ, Cicerchi C, Roncal-Jimenez C, Schrier RW, Berl T. The expression of aquaporin-1 in the medulla of the kidney is dependent on the transcription factor associated with hypertonicity, TonEBP. J Biol Chem 285: 31694-31703, 2010.
30. Li SZ, McDill BW, Kovach PA, Ding L, Go WY, Ho SN, Chen F. Calcineurin-NFATc signaling pathway regulates AQP2 expression in response to calcium signals and osmotic stress. Am J Physiol Cell Physiol 292: C1606-C1616, 2007.
31. Lima IP, Muller MC, Holanda TA, Harhay M, Costa CH, Costa DL. Human immunodeficiency virus/Leishmania infantum in the first foci of urban American visceral leishmaniasis: clinical presentation from 1994 to 2010. Rev Soc Bras Med Trop 46: 156-160, 2013.
32. Lima Verde FA, Lima Verde FA, Lima Verde IA, Silva Junior GB, Daher EF, Lima Verde EM. Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil. J Nephrol 20: 430-436, 2007.
33. Lopez-Rodriguez C, Antos CL, Shelton JM, Richardson JA, Lin F, Novobrantseva TI, Bronson RT, Igarashi P, Rao A, Olson EN. Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression. Proc Natl Acad Sci USA 101: 2392-2397, 2004.
34. Lopez-Ruiz P, Rodriguez-Ubreva J, Cariaga AE, Cortes MA, Colas B. SHP-1 in cell-cycle regulation. Anticancer Agents Med Chem 11: 89-98, 2011.
35. Lorenz U. SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol Rev 228: 342-359, 2009.
36. Mak KM, Lo AC, Lam AK, Yeung PK, Ko BC, Chung SS, Chung SK. Nuclear factor of activated T cells 5 deficiency increases the severity of neuronal cell death in ischemic injury. Neurosignals 20: 237-251, 2012.
37. Mak MC, Lam KM, Chan PK, Lau YB, Tang WH, Yeung PK, Ko BC, Chung SM, Chung SK. Embryonic lethality in mice lacking the nuclear factor of activated T cells 5 protein due to impaired cardiac development and function. PLoS One 6: e19186, 2011.
38. Mauldin IS, Tung KS, Lorenz UM. The tyrosine phosphatase SHP-1 dampens murine Th17 development. Blood 119: 4419-4429, 2012.
39. Nakayama Y, Peng T, Sands JM, Bagnasco SM. The TonE/TonEBP pathway mediates tonicity-responsive regulation of UT-A urea transporter expression. J Biol Chem 275: 38275-38280, 2000.
40. Nandan D, Camargo de OC, Moeenrezakhanlou A, Lopez M, Silverman JM, Subek J, Reiner NE. Myeloid cell IL-10 production in response to Leishmania involves inactivation of glycogen synthase kinase-3beta downstream of phosphatidylinositol-3 kinase. J Immunol 188: 367-378, 2012.
41. Neves BM, Silvestre R, Resende M, Ouaissi A, Cunha J, Tavares J, Loureiro I, Santarem N, Silva AM, Lopes MC, Cruz MT, Cordeiro da SA. Activation of phosphatidylinositol 3-kinase/Akt and impairment of nuclear factor-kappaB: molecular mechanisms behind the arrested maturation/activation state of Leishmania infantum-infected dendritic cells. Am J Pathol 177: 2898-2911, 2010.
42. Oliveira RA, Diniz LF, Teotonio LO, Lima CG, Mota RM, Martins A, Sanches TR, Seguro AC, Andrade L, Silva GB Jr, Liborio AB, Daher EF. Renal tubular dysfunction in patients with American cutaneous Leishmaniasis. Kidney Int 80: 1099-1106, 2011.
43. Oliveira RA, Lima CG, Mota RM, Martins AM, Sanches TR, Seguro AC, Andrade LC, Junior GB, Liborio AB, Daher EF. Renal function evaluation in patients with American cutaneous Leishmaniasis after specific treatment with pentavalent antimonial. BMC Nephrol 13: 44, 2012.
44. Pathak MK, Yi T. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J Immunol 167: 3391-3397, 2001.
45. Poltorak A, He X, Smirnova I, Liu MY, Van HC, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088, 1998.
46. Poole AW, Jones ML. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Cell Signal 17: 1323-1332, 2005.
47. Rauchman MI, Nigam SK, Delpire E, Gullans SR. An osmotically tolerant inner medullary collecting duct cell line from an SV40 transgenic mouse. Am J Physiol Renal Fluid Electrolyte Physiol 265: F416-F424, 1993.
48. Roth I, Leroy V, Kwon HM, Martin PY, Feraille E, Hasler U. Osmoprotective transcription factor NFAT5/TonEBP modulates nuclear factor-kappaB activity. Mol Biol Cell 21: 3459-3474, 2010.
49. Sacks DL, Melby PC. Animal models for the analysis of immune responses to Leishmaniasis. Curr Protoc Immunol: Chapter 19, Unit 19.2, 2001.
50. Shio MT, Hassani K, Isnard A, Ralph B, Contreras I, Gomez MA, Abu-Dayyeh I, Olivier M. Host cell signalling and Leishmania mechanisms of evasion. J Trop Med 2012: 819512, 2012.
51. Silverman JM, Chan SK, Robinson DP, Dwyer DM, Nandan D, Foster LJ, Reiner NE. Proteomic analysis of the secretome of Leishmania donovani. Genome Biol 9: R35, 2008.
52. Siminovitch KA, Neel BG. Regulation of B cell signal transduction by SH2-containing protein-tyrosine phosphatases. Semin Immunol 10: 329-347, 1998.
53. Singh N, Kumar M, Singh RK. Leishmaniasis: current status of available drugs and new potential drug targets. Asian Pac J Trop Med 5: 485-497, 2012.
54. Titus RG, Marchand M, Boon T, Louis JA. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 7: 545-555, 1985.
55. Tortorella C, Simone O, Piazzolla G, Stella I, Antonaci S. Age-related impairment of GM-CSF-induced signalling in neutrophils: role of SHP-1 and SOCS proteins. Ageing Res Rev 6: 81-93, 2007.
56. Tsai TT, Guttapalli A, Agrawal A, Albert TJ, Shapiro IM, Risbud MV. MEK/ERK signaling controls osmoregulation of nucleus pulposus cells of the intervertebral disc by transactivation of TonEBP/OREBP. J Bone Miner Res 22: 965-974, 2007.
57. Valentino L, Pierre J. JAK/STAT signal transduction: regulators and implication in hematological malignancies. Biochem Pharmacol 71: 713-721, 2006.
58. Woo SK, Kwon HM. Adaptation of kidney medulla to hypertonicity: role of the transcription factor TonEBP. Int Rev Cytol 215: 189-202, 2002.
59. Yao C, Chen Y, Sudan B, Donelson JE, Wilson ME. Leishmania chagasi: homogenous metacyclic promastigotes isolated by buoyant density are highly virulent in a mouse model. Exp Parasitol 118: 129-133, 2008.
60. Zanin FH, Coelho EA, Tavares CA, Marques-da-Silva EA, Silva Costa MM, Rezende SA, Gazzinelli RT, Fernandes AP. Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections. Microbes Infect 9: 1070-1077, 2007.
61. Zhou X, Burg MB, Ferraris JD. Water restriction increases renal inner medullary manganese superoxide dismutase (MnSOD). Am J Physiol Renal Physiol 303: F674-F680, 2012.
62. Zhou X, Ferraris JD, Cai Q, Agarwal A, Burg MB. Increased reactive oxygen species contribute to high NaCl-induced activation of the osmoregulatory transcription factor TonEBP/OREBP. Am J Physiol Renal Physiol 289: F377-F385, 2005.
63. Zhou X, Gallazzini M, Burg MB, Ferraris JD. Contribution of SHP-1 protein tyrosine phosphatase to osmotic regulation of the transcription factor TonEBP/OREBP. Proc Natl Acad Sci USA 107: 7072-7077, 2010.
64. Zhou X, Wang H, Burg MB, Ferraris JD. High NaCl-induced inhibition of PTG contributes to activation of NFAT5 through attenuation of the negative effect of SHP-1. Am J Physiol Renal Physiol 305: F362-F369, 2013.
65. Zhou X, Wang H, Burg MB, Ferraris JD. Inhibitory phosphorylation of GSK-3 by AKT, PKA, and PI3K contributes to high NaCl-induced activation of the transcription factor NFAT5 (TonEBP/OREBP). Am J Physiol Renal Physiol 304: F908-F917, 2013.